Explorer
Advertisement
Biotech
Health
Bharat Biotech Temporarily Slows Down Covaxin Production. Here's Why
News
ED Attaches Over Rs 20 Crore Worth Of Assets In Sterling Biotech Bank Fraud Case
Health
Covaxin To Be Evaluated As Covid-19 Vaccine Candidate In US: Bharat Biotech
Health
Bharat Biotech Manufactured Nasal Vaccine Could Be Game-Changer If It Provides Mucosal Immunity: AIIMS Doctor
Health
Covid Vaccine: Bharat Biotech Gets DCGI Permission For Intranasal Booster Dose Trials
India
Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population
India
Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval
Health
Govt Panel Recommends Regular Market Approval For Covishield And Covaxin
India
Receiving Reports That Children Being Administered Covid Jab Other Than Covaxin: Bharat Biotech
Health
Covaxin Now A Universal Covid-19 Vaccine For Adults, Children: Bharat Biotech
Health
Covaxin Booster Dose Shown To Neutralize Omicron, Delta Covid Variants: Bharat Biotech
Health
Covaxin Booster Jabs Trial Shows 'Long-Term Safety With No Adverse Events': Bharat Biotech
Videos
India
Delhiites react over COVID vaccination drive | Ground Report
Short Videos
Advertisement
Advertisement
Advertisement
Top Headlines
India
Cities
India
Cities
Advertisement